MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-AP-20-0000248
Verlen Labs Private Limited
Verlen Labs Private Limited - pharma in Secunderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4.01 Cr
▼ 18% YoY
Net profit · FY 2024
₹1.62 Lakh
Net margin 0.4%
EBITDA · FY 2024
₹2.6 Lakh
EBITDA margin 0.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹97 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Verlen Labs Private Limited
Data last updated:
Verlen Labs Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2016PTC111560. Its GSTIN is 37AAFCV6480P1ZG (Andhra Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tripura Sundari Borra (Managing Director) and Borra Udayabaskar.
Its last annual general meeting (AGM) was held on 23 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Secunderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.01 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹1.62 Lakh (net margin 0.4%) and EBITDA of ₹2.6 Lakh (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 42% over five years.
As per MCA filings, the company has open charges of ₹97 Lakh on record. Court records list 2 cases involving the company, including 1 filed against it; 1 case is pending.
Verlen Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-20-0000248). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Verlen Labs Private Limited
CIN U24100TG2016PTC111560
Registration Number 111560
Incorporation Date 22 August 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 December 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-AP-20-0000248
Recognitions & Rankings of Verlen Labs
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address7 – 1 – 136 137 138/A 138/B First Floor Portion B, Bandimet Begumpet Marredpally Hyderabad, Secunderabad, Telangana, India – 500003
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Verlen Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Verlen Labs Private Limited
The main business activity of Verlen Labs is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Verlen Labs Private Limited FY 2024 filings available
Verlen Labs Private Limited reported revenue of ₹4.01 Cr (down 18% YoY) for FY 2024.
Revenue · FY 2024
₹4.01 Cr ▼ 18%
Net profit · FY 2024
₹1.62 Lakh margin 0.4%
EBITDA · FY 2024
₹2.6 Lakh margin 0.6%
Compounded Annual Growth Rate (CAGR) of Verlen Labs Private Limited
Revenue CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 18%
5 years · compounded
▲ 42%
EBITDA CAGR growth
1 year
▼ 34%
3 years · compounded
▼ 17%
5 years · compounded
▲ 14%
Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 42%. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Verlen Labs Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.6 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.62 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Verlen Labs Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Verlen Labs are in the company report.
Premium access
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Verlen Labs Private Limited
Verlen Labs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tripura Sundari Borra | Managing Director | 10 Jul 2017 | 9 Years 3 Months | Current |
| Borra Udayabaskar Also directs: Ekard Life Sciences Private Limited | Director | 22 Aug 2016 | 10 Years 1 Months | Current |
Peer Comparison of Verlen Labs Private Limited
Verlen Labs Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| A2a Healthcare Private Limited | ₹4.02 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Delhi, India |
| Kaddam Medicos Private Limited | ₹4.02 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Bhiwani, Haryana, India |
| Srisukipharma Private Limited | ₹4.02 Cr (FY 2024) | •••• | •••• | 79.0% | •••• | Vellore, Tamil Nadu, India |
| Ezyspit Solutions Private Limited | ₹4.02 Cr (FY 2022) | •••• | •••• | 1429.0% | •••• | Maratha Hotel Nagpur, Maharashtra, India |
| Algen Remedies Private Limited | ₹4.01 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | New Delhi, Delhi, India |
| Verlen Labs Private Limited this company | ₹4.01 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Secunderabad, Telangana, India |
| Amraph India Private Limited | ₹4.01 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | New Delhi, Delhi, India |
| Chiron Pharmaceuticals Private Limited | ₹4 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Chennai, Tamil Nadu, India |
| Cure Quick Remedies Private Limited | ₹4 Cr (FY 2025) | •••• | •••• | -42.0% | •••• | Haryana, India |
| Astraazin Pharmaceuticals Private Limited | ₹4 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
| Aslan Healthcare Private Limited | ₹3.99 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Verlen Labs by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Verlen Labs Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Verlen Labs Private Limited
Open charges
₹97 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2022 | Axis Bank Limited | ₹97 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Verlen Labs Private Limited
Verlen Labs Private Limited has 2 court cases on record: 1 filed against it, 1 where it is another party. 1 case is pending and 1 is disposed. Status as checked between 01 Oct 2026 and 02 Oct 2026.
Total cases
2
Filed against the company
1
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
| District courts | 1 | 1 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Protium Finance Limited | Pending |
| High Court of Rajasthan | Writ petition | Company is another party | Disposed |
Premium access
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Verlen Labs Private Limited
Employment history and EPFO contributions of people linked to Verlen Labs.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Verlen Labs Private Limited
Verlen Labs Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Pamuluyadav Bandaru ceased to be Director on 18 Jul 2017.
AGM
Verlen Labs Private Limited last Annual general meeting of members was held on 23 Dec 2024 as per latest MCA records.
Filing
Verlen Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited of Rs. 97.00 Lakh registered on 30 May 2022 with Charge ID 100582747 was modified on 21 Jun 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 97.00 Lakh with Charge ID 100582747 was registered on 30 May 2022.
Ceased
Pamuluyadav Bandaru ceased to be Director.
Appointed
Tripura Sundari Borra was appointed as Managing Director.
Appointed
Borra Udayabaskar was appointed as Director.
Incorporation
22 Aug 2016
Verlen Labs Private Limited was registered on 22 Aug 2016 with Roc Hyderabad & aged 10 years 2 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Verlen Labs Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Verlen Labs Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Verlen Labs Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Verlen Labs Private Limited
Verlen Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAFCV6480P1ZG | Andhra Pradesh | Active | 13 Apr 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Verlen Labs Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Verlen Labs Private Limited
Verlen Labs is an active private limited company based in Secunderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 August 2016 (10+ years old) and is registered under CIN U24100TG2016PTC111560.
Verlen Labs reported revenue of ₹4.01 Cr for FY 2024 (down 18% YoY).
Verlen Labs has 2 current directors:
- Tripura Sundari Borra - Managing Director
- Borra Udayabaskar - Director
Verlen Labs reported a net profit of ₹1.62 Lakh (net margin 0.4%) and EBITDA of ₹2.6 Lakh (EBITDA margin 0.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Verlen Labs is 18% over three years and 42% over five years. In the latest year (FY 2024) revenue fell 18%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Verlen Labs is 37AAFCV6480P1ZG, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Verlen Labs is U24100TG2016PTC111560. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Verlen Labs has 2 court cases on record: 1 filed against it. 1 is pending. Most are in the high courts.
Verlen Labs was incorporated on 22 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Verlen Labs by revenue are A2a Healthcare Private Limited, Kaddam Medicos Private Limited, Srisukipharma Private Limited, Ezyspit Solutions Private Limited, Algen Remedies Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Pamuluyadav Bandaru ceased to be Director on 18 Jul 2017. Tripura Sundari Borra was appointed as Managing Director on 10 Jul 2017. Borra Udayabaskar was appointed as Director on 22 Aug 2016.